2023-05-012024-04-302024-04-30false06842276RERUM INGREDIENTS LIMITED2024-09-2374909iso4217:GBPxbrli:pure068422762023-05-01068422762024-04-30068422762023-05-012024-04-30068422762022-05-01068422762023-04-30068422762022-05-012023-04-3006842276bus:SmallEntities2023-05-012024-04-3006842276bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3006842276bus:FullAccounts2023-05-012024-04-3006842276bus:PrivateLimitedCompanyLtd2023-05-012024-04-3006842276core:WithinOneYear2024-04-3006842276core:AfterOneYear2024-04-3006842276core:WithinOneYear2023-04-3006842276core:AfterOneYear2023-04-3006842276core:ShareCapital2024-04-3006842276core:SharePremium2024-04-3006842276core:RevaluationReserve2024-04-3006842276core:OtherReservesSubtotal2024-04-3006842276core:RetainedEarningsAccumulatedLosses2024-04-3006842276core:ShareCapital2023-04-3006842276core:SharePremium2023-04-3006842276core:RevaluationReserve2023-04-3006842276core:OtherReservesSubtotal2023-04-3006842276core:RetainedEarningsAccumulatedLosses2023-04-3006842276core:LandBuildings2024-04-3006842276core:PlantMachinery2024-04-3006842276core:Vehicles2024-04-3006842276core:FurnitureFittings2024-04-3006842276core:OfficeEquipment2024-04-3006842276core:NetGoodwill2024-04-3006842276core:IntangibleAssetsOtherThanGoodwill2024-04-3006842276core:ListedExchangeTraded2024-04-3006842276core:UnlistedNon-exchangeTraded2024-04-3006842276core:LandBuildings2023-04-3006842276core:PlantMachinery2023-04-3006842276core:Vehicles2023-04-3006842276core:FurnitureFittings2023-04-3006842276core:OfficeEquipment2023-04-3006842276core:NetGoodwill2023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2023-04-3006842276core:ListedExchangeTraded2023-04-3006842276core:UnlistedNon-exchangeTraded2023-04-3006842276core:LandBuildings2023-05-012024-04-3006842276core:PlantMachinery2023-05-012024-04-3006842276core:Vehicles2023-05-012024-04-3006842276core:FurnitureFittings2023-05-012024-04-3006842276core:OfficeEquipment2023-05-012024-04-3006842276core:NetGoodwill2023-05-012024-04-3006842276core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3006842276core:ListedExchangeTraded2023-05-012024-04-3006842276core:UnlistedNon-exchangeTraded2023-05-012024-04-3006842276core:MoreThanFiveYears2023-05-012024-04-3006842276core:Non-currentFinancialInstruments2024-04-3006842276core:Non-currentFinancialInstruments2023-04-3006842276dpl:CostSales2023-05-012024-04-3006842276dpl:DistributionCosts2023-05-012024-04-3006842276core:LandBuildings2023-05-012024-04-3006842276core:PlantMachinery2023-05-012024-04-3006842276core:Vehicles2023-05-012024-04-3006842276core:FurnitureFittings2023-05-012024-04-3006842276core:OfficeEquipment2023-05-012024-04-3006842276dpl:AdministrativeExpenses2023-05-012024-04-3006842276core:NetGoodwill2023-05-012024-04-3006842276core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3006842276dpl:GroupUndertakings2023-05-012024-04-3006842276dpl:ParticipatingInterests2023-05-012024-04-3006842276dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3006842276core:ListedExchangeTraded2023-05-012024-04-3006842276dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3006842276core:UnlistedNon-exchangeTraded2023-05-012024-04-3006842276dpl:CostSales2022-05-012023-04-3006842276dpl:DistributionCosts2022-05-012023-04-3006842276core:LandBuildings2022-05-012023-04-3006842276core:PlantMachinery2022-05-012023-04-3006842276core:Vehicles2022-05-012023-04-3006842276core:FurnitureFittings2022-05-012023-04-3006842276core:OfficeEquipment2022-05-012023-04-3006842276dpl:AdministrativeExpenses2022-05-012023-04-3006842276core:NetGoodwill2022-05-012023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3006842276dpl:GroupUndertakings2022-05-012023-04-3006842276dpl:ParticipatingInterests2022-05-012023-04-3006842276dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-3006842276core:ListedExchangeTraded2022-05-012023-04-3006842276dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-3006842276core:UnlistedNon-exchangeTraded2022-05-012023-04-3006842276core:NetGoodwill2024-04-3006842276core:IntangibleAssetsOtherThanGoodwill2024-04-3006842276core:LandBuildings2024-04-3006842276core:PlantMachinery2024-04-3006842276core:Vehicles2024-04-3006842276core:FurnitureFittings2024-04-3006842276core:OfficeEquipment2024-04-3006842276core:AfterOneYear2024-04-3006842276core:WithinOneYear2024-04-3006842276core:ListedExchangeTraded2024-04-3006842276core:UnlistedNon-exchangeTraded2024-04-3006842276core:ShareCapital2024-04-3006842276core:SharePremium2024-04-3006842276core:RevaluationReserve2024-04-3006842276core:OtherReservesSubtotal2024-04-3006842276core:RetainedEarningsAccumulatedLosses2024-04-3006842276core:NetGoodwill2023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2023-04-3006842276core:LandBuildings2023-04-3006842276core:PlantMachinery2023-04-3006842276core:Vehicles2023-04-3006842276core:FurnitureFittings2023-04-3006842276core:OfficeEquipment2023-04-3006842276core:AfterOneYear2023-04-3006842276core:WithinOneYear2023-04-3006842276core:ListedExchangeTraded2023-04-3006842276core:UnlistedNon-exchangeTraded2023-04-3006842276core:ShareCapital2023-04-3006842276core:SharePremium2023-04-3006842276core:RevaluationReserve2023-04-3006842276core:OtherReservesSubtotal2023-04-3006842276core:RetainedEarningsAccumulatedLosses2023-04-3006842276core:NetGoodwill2022-05-0106842276core:IntangibleAssetsOtherThanGoodwill2022-05-0106842276core:LandBuildings2022-05-0106842276core:PlantMachinery2022-05-0106842276core:Vehicles2022-05-0106842276core:FurnitureFittings2022-05-0106842276core:OfficeEquipment2022-05-0106842276core:AfterOneYear2022-05-0106842276core:WithinOneYear2022-05-0106842276core:ListedExchangeTraded2022-05-0106842276core:UnlistedNon-exchangeTraded2022-05-0106842276core:ShareCapital2022-05-0106842276core:SharePremium2022-05-0106842276core:RevaluationReserve2022-05-0106842276core:OtherReservesSubtotal2022-05-0106842276core:RetainedEarningsAccumulatedLosses2022-05-0106842276core:AfterOneYear2023-05-012024-04-3006842276core:WithinOneYear2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3006842276core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3006842276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3006842276core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3006842276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3006842276bus:Director12023-05-012024-04-3006842276bus:Director22023-05-012024-04-30

RERUM INGREDIENTS LIMITED

Registered Number
06842276
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2024

RERUM INGREDIENTS LIMITED
Company Information
for the year from 1 May 2023 to 30 April 2024

Directors

VAN KLEEF, Natalie Jane
VAN KLEEF, Serge

Registered Address

6 Nottingham Science & Technology Park
Nottingham
NG7 2RF

Registered Number

06842276 (England and Wales)
RERUM INGREDIENTS LIMITED
Balance Sheet as at
30 April 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets49,4173,565
9,4173,565
Current assets
Stocks58,8687,950
Debtors643,49316,287
Cash at bank and on hand183,496156,763
235,857181,000
Creditors amounts falling due within one year7(80,457)(102,787)
Net current assets (liabilities)155,40078,213
Total assets less current liabilities164,81781,778
Creditors amounts falling due after one year8(26,211)(30,824)
Provisions for liabilities9(2,234)(1,056)
Net assets136,37249,898
Capital and reserves
Called up share capital2020
Profit and loss account136,35249,878
Shareholders' funds136,37249,898
The financial statements were approved and authorised for issue by the Board of Directors on 23 September 2024, and are signed on its behalf by:
VAN KLEEF, Serge
Director
Registered Company No. 06842276
RERUM INGREDIENTS LIMITED
Notes to the Financial Statements
for the year ended 30 April 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year33
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 May 2315,33115,331
Additions7,7357,735
At 30 April 2423,06623,066
Depreciation and impairment
At 01 May 2311,76611,766
Charge for year1,8831,883
At 30 April 2413,64913,649
Net book value
At 30 April 249,4179,417
At 30 April 233,5653,565
5.Stocks

2024

2023

££
Finished goods8,8687,950
Total8,8687,950
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables18,37012,373
Amounts owed by associates and joint ventures / participating interests24,4941
Other debtors6293,913
Total43,49316,287
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables16,38144,884
Bank borrowings and overdrafts4,4374,645
Amounts owed to related parties66,000
Taxation and social security42,44529,207
Accrued liabilities and deferred income17,18818,051
Total80,457102,787
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts26,21130,824
Total26,21130,824
9.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)2,2341,056
Total2,2341,056
10.Related party transactions
During the year there were transactions between associated companies, totalling £24,494 at the year end (2023 £6000). There was also an amount of £6 owed, interest free, to the director (2023: £0)
11.Further information regarding the company's financial position
There is a fixed and floating charge over the companies assets held by Bibby Financial Services Ltd.